Jazz Pharmaceuticals (JAZZ) Acquisitions (2012 - 2014)
Jazz Pharmaceuticals (JAZZ) recorded quarterly Acquisitions of $828.7 million in Q1 2014, up 32.74% quarter-over-quarter from $624.3 million in Q2 2012.
Jazz Pharmaceuticals (JAZZ) Acquisitions (2012 - 2014) Analysis & Trends
Jazz Pharmaceuticals' Acquisitions history runs 2 years deep, the most recent figure standing at $828.7 million for Q1 2014.
- In Q1 2014, Acquisitions changed N/A year-over-year to $828.7 million; the TTM figure through Dec 2014 stood at $828.7 million (changed N/A YoY), while the FY2021 annual figure was $6.2 billion, changed N/A from the prior year.
- Acquisitions was $828.7 million for Q1 2014 at Jazz Pharmaceuticals, up from $624.3 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $828.7 million in Q1 2014 to a low of -$81.8 million in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 14.25 Bn | 12.41 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 828.68 Mn |
| Jun 30, 2012 | 624.28 Mn |
| Mar 31, 2012 | -81.75 Mn |